Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
boston blog main
boston top stories
clinical trials
drugs
life sciences
national top stories
accelerated approval
acute hepatic porphyria
adha
alafair bioscienes
alnylam pharmaceuticals
alto
amgen
aminolevulinic acid
amyotrophic lateral sclerosis
apps
arlington
austin
boston
cerebral palsy
cholesterol
co-working
coder technologies
crunchfund
dallas
data
fda
funding
gabriella rowe
givosiran
grace rodriguez
houston
impact hub houston
inclisiran
innovation
investment
jr reale
ldl
lemnos
What
drug
3
×
nasdaq
3
×
big
medicine
aces
alnylam
announced
based
candidate
catch
ceo
cholesterol
cleared
dallas
data
delivery
far
flexible
inclisiran
innovation
interference
key
latest
leaves
let’s
licensed
lowering
market
meant
medco
medicines
neos
new
news
ok
open
passed
pharmaceuticals
pricing
rna
Language
unset
Current search:
nasdaq
×
drug
×
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
Delivery Robots in Big D, Rodriguez Leaves the Station, & More TX Tech
@xconomy.com
5 years ago
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug
